Status: Not yet recruiting
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
Prospective, multi-center open label study of HLA-partially to fully matched allogeneic cryopreserved deceased donor bone marrow transplantation and living donor transplantation for patients with hematologic malignancies.
Participants needed: 300
Trial details
Age: 12-75Biological sex: AllType: InterventionalSponsor: Ossium Health, Inc.Updated: Jul 20, 2026
Eligibility criteria
Patient has the ability to provide informed consent according to the applicable... [+23]
Autologous transplant within 6 months [+12]